Literature DB >> 12030729

Annual lung function changes in young patients with chronic lung disease.

P J F M Merkus1, H A W M Tiddens, J C de Jongste.   

Abstract

Reference equations for ventilatory function that use different statistical models may introduce artifacts that affect the estimated change of lung function during growth in young subjects. The effect of differently modelled reference equations on the estimated annual change of forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) in young patients with chronic lung disease was assessed. Four frequently used reference equations were used to describe the longitudinal changes of FEV1 and FVC in 52 patients (23 females) with cystic fibrosis (CF) during a mean follow-up of 3.9 yrs. Choice of reference equations directly affected value and, most importantly, estimated annual change of FVC and FEV1. Mean+/-SD annual change of FEV1 varied from 2.2+/-6.2 to -2.2+/-3.6% of predicted. For two reference equations the estimated individual changes of FEV1 and FVC in CF were positively correlated with mean individual age. This probably reflects underestimation of deteriorating lung function. Variability of annual change was independent of age only when reference equations that were designed to accurately predict lung function during the pubertal growth spurt were used. These findings have implications for patient care and clinical research.

Entities:  

Mesh:

Year:  2002        PMID: 12030729     DOI: 10.1183/09031936.02.00254902

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Reference ranges for spirometry across all ages: a new approach.

Authors:  Sanja Stanojevic; Angie Wade; Janet Stocks; John Hankinson; Allan L Coates; Huiqi Pan; Mark Rosenthal; Mary Corey; Patrick Lebecque; Tim J Cole
Journal:  Am J Respir Crit Care Med       Date:  2007-11-15       Impact factor: 21.405

2.  Early detection of lung function decrements in children and adolescents with cystic fibrosis using new reference values.

Authors:  Angela Zacharasiewicz; Sabine Renner; Flora Haderer; Michael Weber; Eleonore Dehlink; Zsolt Szepfalusi; Thomas Frischer
Journal:  Wien Klin Wochenschr       Date:  2017-03-09       Impact factor: 1.704

3.  Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial.

Authors:  A Clement; A Tamalet; E Leroux; S Ravilly; B Fauroux; J-P Jais
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

4.  Lessons learned from a randomized trial of airway secretion clearance techniques in cystic fibrosis.

Authors:  Marci K Sontag; Alexandra L Quittner; Avani C Modi; Joni M Koenig; Don Giles; Christopher M Oermann; Michael W Konstan; Robert Castile; Frank J Accurso
Journal:  Pediatr Pulmonol       Date:  2010-03

5.  Improving rate of decline of FEV1 in young adults with cystic fibrosis.

Authors:  C Que; P Cullinan; D Geddes
Journal:  Thorax       Date:  2005-12-29       Impact factor: 9.139

6.  Heritability of lung disease severity in cystic fibrosis.

Authors:  Lori L Vanscoy; Scott M Blackman; Joseph M Collaco; Amanda Bowers; Teresa Lai; Kathleen Naughton; Marilyn Algire; Rita McWilliams; Suzanne Beck; Julie Hoover-Fong; Ada Hamosh; Dave Cutler; Garry R Cutting
Journal:  Am J Respir Crit Care Med       Date:  2007-03-01       Impact factor: 21.405

7.  Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis.

Authors:  J Twiss; A W Stewart; C A Byrnes
Journal:  Thorax       Date:  2006-02-07       Impact factor: 9.139

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.